← All ETFs
Compare ETFs
4 funds side by side
How to read this: These ETFs report returns on different bases (Total Return, Price Return), so the return figures are not directly comparable. You are comparing an accumulating and a distributing ETF. Returns are shown as total return where available, so the distributing fund is not unfairly penalised for paying dividends out as cash.
Growth of €100, side by side
iShares iBonds Dec 2027 Term € Corp UCITS ETF +11.2%State Street® SPDR® S&P® Dividend ETF +28.6%iShares $ Treasury Bond 1-3yr UCITS ETF +6.7%iShares $ Treasury Bond 1-3yr UCITS ETF +0.8%
Each fund rebased to 100 at the start of the shared window — weekly closing prices, end-of-day. Past performance does not predict the future.
|
iShares iBonds Dec 2027 Term € Corp UCITS ETF
iShares
|
State Street® SPDR® S&P® Dividend ETF
SPDR
|
iShares $ Treasury Bond 1-3yr UCITS ETF
iShares
|
iShares $ Treasury Bond 1-3yr UCITS ETF
iShares
|
|
|---|---|---|---|---|
| 1-yr return | +1.7% Total Return | +13.5% Price Return | +1.2% Total Return | +3.2% Total Return |
| TER (yearly cost) | 0.12% | 0.35% | 0.10% | 0.07% lowest cost |
| Dividends | Reinvests dividends (accumulating) | Unknown | Reinvests dividends (accumulating) | Pays you cash (distributing) |
| How it’s built | Owns the shares (physical) | Owns the shares (physical) | Owns the shares (physical) | Owns the shares (physical) |
| What it holds | Bonds | Bonds | Bonds | Bonds |
| Index | Bloomberg MSCI December 2027 Maturity EUR Corporate ESG Screened Index | S&P High Yield Dividend Aristocrats Index | Not stated | Not stated |
| Fund size | €1.3B | €19.8B | €12.5B | €10.9B |
| Home country (domicile) | IE | US | IE | IE |
| Currency | EUR | USD | EUR | USD |
| Primary ticker | IB27 | SDY | IBTE | IDBT |
| ISIN | IE000ZOI8OK5 | US78464A7634 | IE00BDFK1573 | IE00B14X4S71 |
Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.